About this trial
The goal of this clinical trial is to compare 3 different types of PRP in androgenetic alopecia patients. The main questions it aims to answer:
Does Redlight enhanced, Blue light enhanced, or traditional PRP result in higher hair density and health? Does Redlight enhanced, Blue light enhanced, or traditional PRP result in other improved hair metrics.
Participants will consent to a PRP treatment but will be blinded to the type. They will then be asked to return for Tricholab analysis at set post-operative timepoints to record changes in hair metrics (Baseline, 1 month, 3 months, 6 months, 9 months, 12 months).
Eligibility criteria
Qualifiers
Age 18-65
Diagnosed Androgenetic Alopecia
Willing to comply with protocol and follow up
Disqualifiers
Active scalp infection or disease
Prior PRP within last 6 months
Use of hair growth medication topical or oral
Platelet dysfunction or anticoagulation
Trial design
Treatments tested in this trial
- Platelet-Rich Plasma (PRP) Injections
- Red-light photobiomodulation with cooling
- Blue-light photobiomodulation
Treatment groups
Locations
Sponsors and collaborators
Kimberly Meathrel
Lead sponsor
BespokeSkin MD
Sponsor institution